Literature DB >> 19084158

Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.

Yusuf Yakupogullari1, Baris Otlu, Muruvvet Dogukan, Canan Gursoy, Ebru Korkmaz, Ahmet Kizirgil, Mehmet Ozden, Riza Durmaz.   

Abstract

BACKGROUND: The nosocomial spread of pan-antibiotic-resistant nonfermentative bacteria is an increasing concern. This study investigated the microbiologic and epidemiologic characteristics of a hospital outbreak due to alginate-producing, pan-antibiotic-resistant Pseudomonas aeruginosa (PAR-Pa).
METHODS: All patients with infection with a P. aeruginosa strain that was resistant to all Clinic Laboratory Standards Institute-suggested antimicrobial agents between November 2004 and May 2005 were included in the study. Alginate production detection and pulsed-field gel electrophoresis (PFGE) typing were done for the patient and environmental surveillance isolates. A matched case-control study was performed to identify risk factors and evaluate outcomes.
RESULTS: PFGE analysis of a total of 35 PAR-Pa isolates (28 patient and 7 environmental surveillance isolates) identified a single epidemic clone as responsible for the outbreak. All epidemic isolates were alginate-producing and susceptible only to colistin. The Student t-test demonstrated that a longer stay in the intensive care unit (ICU) (6.64 days vs 1.83 days; P < .05) significantly increased the risk of PAR-Pa infection. Systemic PAR-Pa infection resulted in higher mortality (85.7% vs 27.8%; P < .05). Multivariate analysis determined that therapeutic failure (odds ratio = 24.7; 95% confidence interval = 4.144 to 147.221; P < .05) was the independent risk factor related to this high mortality. Localized PAR-Pa infections were associated with longer hospital stays (46.2% vs 14.4%; P < .05) and higher rates of surgery (85.7% vs 15.4%; P < .05) and amputation (42.8% vs 0%; P < .05). The recovery of the pathogen from staff hands and frequently handled surfaces suggests possible handborne transmission. Improved hygienic standards and application of strict contact precautions, including isolation, reduced the spread of the pathogen.
CONCLUSION: This study illustrates the ability of pan-antibiotic-resistant P. aeruginosa to cause an outbreak with significant mortality and stresses the need for precautions to prevent the spread of such highly resistant strains.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19084158     DOI: 10.1016/j.ajic.2008.07.006

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  6 in total

Review 1.  Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit.

Authors:  Marin H Kollef; Yoav Golan; Scott T Micek; Andrew F Shorr; Marcos I Restrepo
Journal:  Clin Infect Dis       Date:  2011-09       Impact factor: 9.079

Review 2.  Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

3.  Thirteen years of antibiotic susceptibility surveillance of Pseudomonas aeruginosa from intensive care units and urology services in the Netherlands.

Authors:  P D Croughs; B Li; J A A Hoogkamp-Korstanje; E Stobberingh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-08       Impact factor: 3.267

4.  Bloodstream infections in patients with or without cancer in a large community hospital.

Authors:  M M E M Bos; L S Smeets; I Dumay; E de Jonge
Journal:  Infection       Date:  2013-05-05       Impact factor: 3.553

Review 5.  Biofilms in infections of the eye.

Authors:  Paulo J M Bispo; Wolfgang Haas; Michael S Gilmore
Journal:  Pathogens       Date:  2015-03-23

6.  An outbreak of extremely drug-resistant Pseudomonas aeruginosa in a tertiary care pediatric hospital in Italy.

Authors:  Marta Ciofi Degli Atti; Paola Bernaschi; Michaela Carletti; Ida Luzzi; Aurora García-Fernández; Alice Bertaina; Annamaria Sisto; Franco Locatelli; Massimiliano Raponi
Journal:  BMC Infect Dis       Date:  2014-09-10       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.